We demonstrate that sotagliflozin is effective in alleviating the otherwise abnormally elevated ER stress in major CF organs, including the lungs, intestine, pancreas, and liver, especially in the IRE1α-mediated UPR pathway. The gene discussed is ERN1; the disease is cystic fibrosis.